RECRUITING

Sleep Restriction Therapy (SRT) for Sleep Problems in Children With Autism

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this open label trial is to examine the acceptability, tolerability, and feasibility and preliminary effectiveness of sleep restriction therapy for sleep problems in children with autism spectrum disorder (ASD). Treatment will be delivered via secure telemedicine platform and consist of parent-training in delivering the intervention.

Official Title

Sleep Restriction Therapy (SRT) for Sleep Problems in Children With Autism Spectrum Disorder

Quick Facts

Study Start:2025-02-11
Study Completion:2027-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06627205

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:6 Years to 12 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * diagnosed with autism spectrum disorder (based on history, review of available medical records including diagnostic testing, e.g., Autism Diagnostic Observation Schedule and/or Autism Diagnostic Interview-Revised, Childhood Autism Rating Scale-2)
  2. * with sleep disturbances (based on clinical interview, and Sleep Disturbance Scale for Children score \> 38)
  3. * stable pre-existing medication plans for at least 2 weeks
  4. * no planned changes in psychosocial and biomedical interventions during the intervention
  5. * an English-speaking parent able to consistently participate in study procedures
  6. * reside in California, USA
  1. * parent or child diagnosed with severe psychiatric disorder or unstable medical problem
  2. * children with active seizures or epilepsy
  3. * primary sleep disorder is a circadian rhythm sleep-wake disorder, as determined by the sleep interview and Children's ChronoType Questionnaire.
  4. * current active trial of sleep restriction therapy or history of an adequate trial of sleep restriction therapy.

Contacts and Locations

Study Contact

Emma K Baker, MPsych(Clin), PhD
CONTACT
6507361235
ekbaker@stanford.edu
Robin Libove, BS
CONTACT
6507361235
rlibove@stanford.edu

Principal Investigator

Emma K Baker, MPsych(Clin), PhD
PRINCIPAL_INVESTIGATOR
Stanford University

Study Locations (Sites)

Stanford University
Stanford, California, 94305
United States

Collaborators and Investigators

Sponsor: Stanford University

  • Emma K Baker, MPsych(Clin), PhD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-02-11
Study Completion Date2027-12

Study Record Updates

Study Start Date2025-02-11
Study Completion Date2027-12

Terms related to this study

Keywords Provided by Researchers

  • Autism
  • Sleep
  • Intervention

Additional Relevant MeSH Terms

  • Autism Spectrum Disorder (ASD)
  • Autism